The Hematology Department under CoE in Internal Medicine operates proudly with our immunologist from Harvard University and hematologists from multiple Chinese 3A hospitals, who are both experienced clinicians and established researchers. Under direct management of Medpoint, a famous healthcare operator in the US, we benchmark ourselves to the state-of-art QC standards in both China and overseas, and adopt a "small nursing units" concept to take better care of our patients. The Department covers a full range of services, including diagnosis/treatment for various hematologic/lymphatic diseases, from regular and benign conditions to refractory and rare diseases, resuscitation of critical patients, as well as utilization of advanced techniques such as autologous/allogeneic hematopoietic stem cell transplantation, cell therapy, and immunotherapy. We plan to conduct clinical research and technological cooperations with foreign research institutes, in order to synchronize us with the most advanced hematologic techniques around the world.
At the Hematology Department, we deliver evidence-based medical services with a MDT-approach, bringing the most up-to-date solutions to our patients through our remote consulting channels with world-renowned hematologists.
